Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 9
Submit an article Journal homepage
225
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

BEAM conditioning regimen ensures better progression-free survival compared with TEAM but not with FEAM in lymphoma patients undergoing autologous stem cell transplant

Francesco MarchesiHematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy; Correspondence[email protected]
,
Saveria CapriaDivision of Hematology, Department of Translational and Precision Medicine, University of Rome ‘Sapienza’, Rome, Italy;
,
Mariangela PedataStem Cell Transplant Program of AORN Cardarelli, Naples, Italy;
,
Irene TerrenatoBiostatistics and Bioinformatic Unit, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy;
,
Laura BallottaDivision of Hematology, Department of Translational and Precision Medicine, University of Rome ‘Sapienza’, Rome, Italy;
,
Cira RiccardiStem Cell Transplant Program of AORN Cardarelli, Naples, Italy;
,
Elena PapaHematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy;
,
Costantino RiemmaDivision of Hematology, Department of Translational and Precision Medicine, University of Rome ‘Sapienza’, Rome, Italy;
,
Silvia TrisoliniDivision of Hematology, Department of Translational and Precision Medicine, University of Rome ‘Sapienza’, Rome, Italy;
,
Maria CelentanoStem Cell Transplant Program of AORN Cardarelli, Naples, Italy;
,
Giulia RegazzoGenomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy;
,
Felicetto FerraraHematology of AORN Cardarelli, Naples, Italy
,
Andrea MengarelliHematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy;
&
Alessandra PicardiStem Cell Transplant Program of AORN Cardarelli, Naples, Italy;
show all
Pages 2238-2241 | Received 28 Mar 2020, Accepted 28 Apr 2020, Published online: 18 May 2020

References

  • Damaj G, Cornillon J, Bouabdallah K, et al. Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review. Bone Marrow Transplant. 2017;52(7):941–949.
  • Schmitz N, Lymphoma Working Party of the European Group for Blood and Marrow Transplantation, Pfistner B, Sextro M, et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin’s disease: a randomized trial. Lancet. 2002;359(9323):2065–2071.
  • Joffe E, Rosenberg D, Rozovski U, et al. Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma. Bone Marrow Transplant. 2018;53(1):29–33.
  • Musso M, Scalone R, Marcacci G, et al. Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study. Bone Marrow Transplant. 2010;45(7):1147–1153.
  • Musso M, Messina G, Di Renzo N, et al. Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen. Br J Haematol. 2016;172(1):111–121.
  • Olivieri J, Mosna F, Pelosini M, et al. A comparison of the conditioning regimens BEAM and FEAM for autologous hematopoietic stem cell transplantation in lymphoma: an observational study on 1038 patients from Fondazione Italiana Linfomi. Biol Blood Marrow Transplant. 2018;24(9):1814–1822.
  • Marchesi F, Capria S, Giannarelli D, et al. BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant. Bone Marrow Transplant. 2018;53(8):1051–1054.
  • Sellner L, EBMT Lymphoma Working Party, Boumendil A, Finel H, et al. Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT. Bone Marrow Transplant. 2016;51(2):212–218.
  • Mills W, Chopra A, McMillan A, et al. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin’s lymphoma. JCO. 1995;13(3):588–595.
  • Cheson BD, Fisher RI, Barrington SF, Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin’s Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–3067.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.